ARLINGTON, Va., Sept. 23 /PRNewswire/ -- BioInformatics, LLC (http://www.gene2drug.com), the leading market research and consulting firm serving the life science industry, announces the publication of its latest report, "Protein Research: Strategies for Marketing to Chemists and Biologists." A joint effort between BioInformatics, LLC and the American Chemical Society, the report is designed to help suppliers of protein research tools and technologies identify workflow patterns and applications, discover unmet technology needs and explore instrument-purchasing drivers among biologists and chemists.
"A more in-depth understanding of the needs of scientists studying protein research is of growing importance as the field becomes more complex and funding sources become harder to obtain," observed Dr. Tamara Zemlo, Director of Syndicated Research and Analysis for BioInformatics, LLC. "Furthermore, we have identified significant overlap in how biologists and chemists use the equipment, thereby allowing companies to streamline the marketing effort to appeal to scientists in both disciplines."
By exploring the usage and purchase drivers behind both the higher dollar mass spectrometry and HPLC instrumentation, and the less expensive electrophoresis equipment products, manufacturers and scientists alike can understand what, in addition to cost, is influencing purchase decisions. This study explores how these preferences play out differently (and the same) between biologists and chemists.
Designed to help identify key areas of investigation among protein
researchers, perceived bottlenecks, potential budgetary implications and
customer perceptions of leading providers of instrumentation, this
benchmarking study allows suppliers to gain keen insight into the evolving
needs of their protein research customers, while more clearly defining
certain industry-wide best practices. The information in this re
|SOURCE BioInformatics, LLC|
Copyright©2008 PR Newswire.
All rights reserved